Scholars Central

Review articlePublished 2020

INTELLECTUAL CAPITAL OF PHARMACEUTICAL COMPANIES AS THE CHARACTER OF THE HIGH-PROFILE INDUSTRY

Authors: Istianingsih

Systematic Reviews in Pharmacy

Volume 11 · Issue 12 · Pages 2078–2083

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This study aims to examine the impact of this type of industry on the extent of disclosure of intellectual capital of pharmaceutical companies. The type of industry in this study is divided into two, namely the high profile and low profile industries. This study also examines the impact of firm size on intellectual capital disclosure. This research was conducted on all companies listed on the Indonesia Stock Exchange for five years from 2014 to 2018. Path analysis was used to analyze the research data. The results showed that pharmaceutical companies, which were a high profile industry, proved to be more intense in disclosing their intellectual capital ownership than other industries. The research also found that the larger the company size, the more encouraging them to disclose their intellectual capital ownership in their annual reports.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Istianingsih”